Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP526336.RASVs0ZYrfIvofjF5DJgRPZeI7gP4RDvE4Qz8Rc_ZO1OI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP526336.RASVs0ZYrfIvofjF5DJgRPZeI7gP4RDvE4Qz8Rc_ZO1OI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP526336.RASVs0ZYrfIvofjF5DJgRPZeI7gP4RDvE4Qz8Rc_ZO1OI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP526336.RASVs0ZYrfIvofjF5DJgRPZeI7gP4RDvE4Qz8Rc_ZO1OI130_provenance.
- NP526336.RASVs0ZYrfIvofjF5DJgRPZeI7gP4RDvE4Qz8Rc_ZO1OI130_assertion description "[To this end, experience with DNMT inhibitors in hematologic malignancies other than MDS is reviewed in an effort to better understand the therapeutic potential of these agents and to define areas of future exploration in these settings.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526336.RASVs0ZYrfIvofjF5DJgRPZeI7gP4RDvE4Qz8Rc_ZO1OI130_provenance.
- NP526336.RASVs0ZYrfIvofjF5DJgRPZeI7gP4RDvE4Qz8Rc_ZO1OI130_assertion evidence source_evidence_literature NP526336.RASVs0ZYrfIvofjF5DJgRPZeI7gP4RDvE4Qz8Rc_ZO1OI130_provenance.
- NP526336.RASVs0ZYrfIvofjF5DJgRPZeI7gP4RDvE4Qz8Rc_ZO1OI130_assertion SIO_000772 16341239 NP526336.RASVs0ZYrfIvofjF5DJgRPZeI7gP4RDvE4Qz8Rc_ZO1OI130_provenance.
- NP526336.RASVs0ZYrfIvofjF5DJgRPZeI7gP4RDvE4Qz8Rc_ZO1OI130_assertion wasDerivedFrom befree-2016 NP526336.RASVs0ZYrfIvofjF5DJgRPZeI7gP4RDvE4Qz8Rc_ZO1OI130_provenance.
- NP526336.RASVs0ZYrfIvofjF5DJgRPZeI7gP4RDvE4Qz8Rc_ZO1OI130_assertion wasGeneratedBy ECO_0000203 NP526336.RASVs0ZYrfIvofjF5DJgRPZeI7gP4RDvE4Qz8Rc_ZO1OI130_provenance.
- befree-2016 importedOn "2016-02-19" NP526336.RASVs0ZYrfIvofjF5DJgRPZeI7gP4RDvE4Qz8Rc_ZO1OI130_provenance.